The prevention effect of ARB(Candesartan) upon chronic heart failure of the newly hemo-dialysis patients
Not Applicable
- Conditions
- Heart failure and cardiovascular disease in the newly hemo-dialysis patients
- Registration Number
- JPRN-UMIN000000588
- Lead Sponsor
- Osaka University, Graduate School of Medicine, Devision of Nephrology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with cardiovascular and/or cerebrovascular event Patients with severe liver failure and/or lung dysfunction Patients with malignancy which were diagnosed within 3 years Patients who were not suitable for this trial, judged by the attending doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method